ClinicalTrials.Veeva

Menu

Growth Hormone in EB

Cairo University (CU) logo

Cairo University (CU)

Status

Unknown

Conditions

Epidermolysis Bullosa Dystrophica

Treatments

Diagnostic Test: growth hormone level and insulin like growth factor 1

Study type

Observational

Funder types

Other

Identifiers

NCT05390073
Growth in EB

Details and patient eligibility

About

Growth is extremely affected in epidermolysis bullosa patients

Full description

Studying the role of growth hormone and ILGF-1 in EB may pave the to new therapeutic modality that could improve the growth in those children and avoid the irreversible sequelae that affected subjects experience after adulthood

Enrollment

50 estimated patients

Sex

All

Ages

1 month to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children with EB dystrophica

Exclusion criteria

  • Adults with the same disease

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems